Yissum Spinouts Raise $79 million in H1 2020 Despite Coronavirus Uncertainty - PRNewswire

... an AI organ-on-chip drug development company, and Nectin Therapeutics, an immune-oncology biotech focused on cancer therapies. Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in ...
Read Full Article